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Edematous severe acute childhood malnutrition (edematous SAM or ESAM), which includes
kwashiorkor, presents with more overt multi-organ dysfunction than non-edematous SAM
(NESAM). Reduced concentrations and methyl-ﬂux of methionine in 1-carbon metabolism
have been reported in acute, but not recovered, ESAM, suggesting downstream DNA
methylation changes could be relevant to differences in SAM pathogenesis. Here, we assess
genome-wide DNA methylation in buccal cells of 309 SAM children using the 450 K
microarray. Relative to NESAM, ESAM is characterized by multiple signiﬁcantly hypomethylated loci, which is not observed among SAM-recovered adults. Gene expression and
methylation show both positive and negative correlation, suggesting a complex transcriptional response to SAM. Hypomethylated loci link to disorders of nutrition and metabolism,
including fatty liver and diabetes, and appear to be inﬂuenced by genetic variation. Our
epigenetic ﬁndings provide a potential molecular link to reported aberrant 1-carbon metabolism in ESAM and support consideration of methyl-group supplementation in ESAM.
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A

nnually, severe acute malnutrition (SAM) directly contributes to nearly one million deaths of children under age
5 globally, and indirectly to millions more1. Despite
concordant micro- and macro-nutrient deﬁciencies, SAM classically presents as one of two phenotypically distinct forms—edematous SAM (ESAM), which includes the syndromes of
kwashiorkor and marasmic-kwashiorkor, and nonedematous
SAM (NESAM) or marasmus2,3. NESAM is typically characterized by weight loss and wasting, while ESAM is deﬁned by the
presence of bilateral, pitting edema and usually has more overt,
and often more severe, multiorgan dysfunction, including hepatic,
hematopoietic, and gastrointestinal impairment, alongside skin
and hair abnormalities4–7.
Given that ESAM accounts for 50–70% of SAM cases in some
developing countries8, and has different clinical outcomes relative to NESAM, considerable interest remains in gaining a better
understanding of the underlying molecular pathophysiology2,9.
The divergent SAM phenotypes are not fully explained by
environmental, dietary, or infectious factors7,10–12, despite a
substantial catalog of disparate studies describing biochemical
and physiological differences between the two forms13–16,
including recent reports of quantitative shifts in microbiota17,18.
These observations, however, are subject to reverse causation
and provide an incomplete picture of the broad pathophysiological dysfunction that is the hallmark of ESAM19. Moreover,
despite differences in pathophysiology and clinical outcome, the
treatment of SAM has remained largely unchanged and is the
same regardless of form20–22. Although public health strategies
that address food security remain important to SAM23, such
strategies are notoriously difﬁcult to implement and are susceptible to volatility in climate and society. A better understanding of the underlying molecular pathophysiology of ESAM
could provide additional therapeutic insights that could be used
to further improve outcomes and prevent development of the
condition.
There are no deﬁnitive molecular or genetic correlates of acute
childhood ESAM; however, ESAM and NESAM differ biochemically in the ﬂux of constituent metabolites of the 1-carbon
cycle24,25. During steady-state re-feeding, but while still acutely
ill, ESAM patients show a signiﬁcantly lower concentration of the
essential amino acid methionine with slower methyl-group and
total methionine ﬂux25 in the conversion of methionine to Sadenosyl-methionine (SAM-e). SAM-e is the major source of
methyl groups required for the methylation of cellular

components, including the methylation of DNA26–28 during
mitosis. These differences in 1-carbon metabolism between
ESAM and NESAM, however, are not observed after recovery
from SAM, implying that nutritional and dietary recovery
involves a reversal of the biochemical changes observed during
the acute illness. While previous studies have shown altered DNA
methylation in individuals with a history of severe acute malnutrition more generally29,30, none compared DNA methylation
between the edematous and nonedematous forms of SAM, particularly during acute disease. Since the phenotypic differences
that characterize the two forms of SAM are only evident during
acute malnutrition, concomitant molecular changes incurred
during acute illness could potentially highlight important drivers
of the differing pathophysiologies. We hypothesize that in cells
with high mitotic rates, acutely ill children with ESAM will have
lower DNA methylation compared to their NESAM counterparts,
whereas methylation differences among recovered SAM individuals will be less disparate. Given the interrelationship between
DNA methylation, gene regulation, and sequence variation, we
further postulate that the integration of these modalities across
acute and recovered SAM participants might provide valuable
insights to the distinct pathophysiology of ESAM.
Here, we systematically assess DNA methylation at 420,500
genome-wide CpG sites in buccal epithelium DNA samples
obtained from two independent SAM cohorts—309 prospectively
recruited, acutely ill children (Fig. 1; Supplementary Table 1) with
SAM from Malawi and Jamaica and 65 adult SAM survivors from
Jamaica; the latter were retrospectively recruited 16 or more years
after their acute malnutrition event (Fig. 1; Supplementary
Table 1). Methylation is compared between ESAM (cases) and
NESAM (controls), and differentially methylated sites are then
interrogated for their corresponding gene expression proﬁles and
surrounding single nucleotide variation.
Results
Hypomethylation of DNA characterizes acute ESAM. A comparison of genome-wide methylation between acutely ill children
(predischarge, DC samples) with ESAM and NESAM revealed
signiﬁcant methylation differences at 877 CpG sites at a false
discovery rate (FDR) < 0.01, of which 157 were signiﬁcant at
a conservative Bonferroni-corrected threshold of P < 1.2 × 10−7
(t test; Fig. 2a). The mean absolute difference in methylation betavalues across all signiﬁcant sites was 0.054 (SD 0.02). Consistent
with previous observations of slower methyl-ﬂux in acute ESAM,
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Fig. 1 Overview of sampling timeline across both cohort locations and time points.
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Fig. 2 DNA hypomethylation in ESAM. a The genome position of each locus is plotted against its −log10(P value). Depicted, from the inner to the
outermost ring, are the recovered (DL) single site, acute (DC) single site, and DC cluster-based differential methylation results. Red lines mark the
Bonferroni threshold of signiﬁcance for each analysis. Black (N = 157) and red dots (N = 166) pass this signiﬁcance threshold, in their respective analyses.
Gene symbols around the plot perimeter represent the gene(s) within 10 kb of the signiﬁcantly differentially methylated clusters (outer ring). Gene symbols
in blue are hypomethylated in ESAM, gene symbols in orange are hypermethylated. b Volcano plot of effect sizes among all DC single sites. c Concordance
of effect size and adjusted statistical signiﬁcance between Jamaica and Malawi DC samples at the N = 157 Bonferroni-signiﬁcant single CpG sites; ten sites
were found to be age-sensitive in each of the country-speciﬁc analyses and were omitted (Methods). All P values are based on t test results from
regression analyses.

all but one differentially methylated site (156/157; 99%) were
signiﬁcantly hypomethylated in ESAM relative to NESAM
(Fig. 2b). Differentially methylated sites showed the same direction of effect (hypo- or hypermethylation) with a consistent effect
size (binomial test, P = 3.08 × 10−14) and magnitude (t test,

lambda adjusted P < 0.05 in both cohorts for 89 of 147 probes
(60%)) in both Jamaican and Malawian samples (Fig. 2c; Supplementary Data 1). Conversely, among samples taken from adult
Jamaican survivors of SAM several years after the acute insult
(delayed, DL samples), we found no evidence for differential
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methylation between ESAM and NESAM using either our stringent Bonferroni-corrected cut-off or the more permissive FDR <
0.01 for signiﬁcance (Fig. 2a), despite being adequately powered
to detect the magnitude differences observed between DC samples. This was again consistent with the previously observed lack
of differences in methyl-ﬂux between ESAM and NESAM at the
time of recovery.
Methylation levels at adjacent CpG sites show strong
correlation31; therefore, to bolster support for differential
methylation of signiﬁcant single CpGs and to limit potential
false-positives, we divided the genome into windows of clustered
CpGs in which adjacent CpGs were within 10 kb and showed the
same direction of effect (Methods). We then compared methylation in ESAM and NESAM averaged across the resulting regions
using the same parameters and covariates as our single-site
analysis. Reassuringly, 102 of the 157 single sites (65.0%) were
found in the resulting 166 Bonferroni-signiﬁcant differentially
methylated clusters (DMCs; t test, P < 3.7 × 10−7, corrected for
135,053 clusters). The majority of the remaining signiﬁcant single
sites (50/55; 91%) fell into clusters that were signiﬁcant at FDR <
0.01 (Supplementary Data 2). An additional 71 Bonferronisigniﬁcant DMCs had no individual CpGs meeting our single-site
cut-off for signiﬁcance, but, as a cluster, showed signiﬁcant
differential methylation between the two groups. All but two of
the 166 signiﬁcant DMCs were hypomethylated in ESAM
compared to NESAM (Fig. 2a).
Hypomethylation has varying effects on gene expression. In
order to better understand the potential regulatory effect of the
differentially methylated loci, we next looked for genic features
that were overrepresented among the CpG sites found within
signiﬁcant DMCs, relative to all tested loci. CpGs within DMCs
were signiﬁcantly enriched over gene bodies (i.e. coding exons
and intervening introns; hypergeometric test, P < 1.4 × 10−6) and
relatively depleted in regulatory regions upstream of the transcription start site (TSS) and over the ﬁrst exon (Fig. 3a).
Moreover, the effect sizes obtained from the single site linear
regression analysis appeared to differ modestly by gene context
annotation (Kruskal−Wallis test, P = 0.047; Supplementary
Fig. 1), with smaller effect sizes at loci within 200 bp of transcription start sites relative to those of CpG loci within 1500 bp of
the TSS (Dunn’s test, P = 0.004), gene bodies (Dunn’s test, P =
0.012), 5′ untranslated regions (UTR; Dunn’s test, P = 0.019), and
the ﬁrst exon (Dunn’s test, P = 0.022). Conversely, the magnitudes of effect sizes of Bonferroni-signiﬁcant loci found within
1500 bp of TSSs were larger than those of CpG loci in intergenic
regions (Dunn’s test, P = 0.013).
The regulatory consequences of methylation on gene activity
vary32, such that the effect of hypomethylation on gene
expression is dependent upon genomic and tissue context;
therefore, to provide further context for our ﬁndings, we assessed
intraindividual correlation between gene expression and genomewide DNA methylation levels in buccal cell samples obtained at
the time of diagnosis from 20 additional Malawian children.
Correlation was determined between CpG methylation and
expression of highly expressed genes (expression levels twofold
above the mean antigenomic background; Methods) found within
10 kb of our DMCs (N = 25; Supplementary Data 2; Fig. 3b).
With the exception of ﬁve CpG probes binned within one DMC
that overlapped two highly expressed genes, PMM2 and
CARHSP1, all methylation values were correlated with the
expression of a single gene. Consistent with the notion that
promoter methylation is generally repressive of gene expression,
correlations at methylation sites within 200 bp of the transcription start site (TSS200) tended to be inversely related to gene
4

expression (two-sided Wilcoxon signed rank test, P = 0.027);
negative correlation between methylation and MED24 gene
expression is exempliﬁed in Fig. 3c. Conversely, methylation at
intergenic regions (IGR) was generally positively associated with
gene expression (two-sided Wilcoxon signed rank test, P =
0.030). However, at other gene regions, and particularly at gene
bodies, CpG methylation showed signiﬁcant positive and negative
correlations with gene expression (Fig. 3b; Supplementary Data 3),
suggesting a more complex transcriptional response to the acute
insult than might have been anticipated from widespread
hypomethylation.
Differentially methylated loci relate to nutrition and
metabolism. Next, we sought to understand the potential disease
relevance of genes within our DMCs. Given the lack of known
genetic loci or molecular correlates for ESAM, we leveraged
publicly available databases and ontologies to provide disease and
molecular context to our hypomethylated genes.
We ﬁrst interrogated the catalog of genome-wide association
studies (GWAS)33 for genes within 10 kb of our signiﬁcant DMCs
that were also implicated by replicated GWAS SNPs of genomewide signiﬁcance. We then agnostically projected the resulting
gene list on to disease traits using their mapped experimental
factor ontologies (EFOs, Methods). Thirty-two EFOs were
represented at least twice by 33 of the 237 genes found within
10 kb of our Bonferroni-signiﬁcant hypomethylated loci (Fig. 4a).
Some of these EFOs occurred frequently when we repeatedly
resampled 237 of the 2436 genes in the GWAS catalog that are
also targeted by the 450 K array (April 24, 2018); for example,
body height was enriched by the random gene set in 93% of
10,000 permutations (Supplementary Fig. 2). This is likely
representative of the number of GWAS that address body height
as well as the number of genes associated with the trait. However,
mapping 33 GWAS catalog genes to 32 associated EFO terms, as
seen in our data, was observed with a probability of only 0.06
among random permutations (i.e. ≥33 GWAS genes mapping to
≥32 EFO terms). Nutrition and cardiometabolic disease were
among the enriched parent ontologies shared across EFO terms
linked to our Bonferroni-signiﬁcant genes (color-shaded in
Fig. 4a).
To further explore the disease relevance of our hypomethylated
loci, we also attempted to place our top candidate genes in the
context of the organ-speciﬁc phenotypes of ESAM using the
human phenotype ontology (HPO) (Methods)34,35, which
includes 34 phenotypes associated with the term kwashiorkor
(Fig. 4b, Supplementary Data 4). These kwashiorkor-related
HPOs, in turn, were associated with 1747 genes. Twenty
kwashiorkor HPO genes were also among the 237 Bonferronisigniﬁcant DMC genes, while 143 overlapped the 1549 genes
associated with FDR < 0.01 signiﬁcant DMCs. We randomly
selected 10,000 different gene combinations from the set of 24,094
genes within 10 kb of all regions tested for differential methylation that were equal in size to either the number of Bonferroni or
FDR-signiﬁcant genes; in each instance we then determined the
number of randomly selected genes overlapping genes linked to
kwashiorkor HPOs. Based on the resulting distributions, we
found that the number of genes overlapping between true DMC
genes and kwashiorkor HPO genes was larger than random by
approximately one standard deviation for Bonferroni-signiﬁcant
genes (Z-score = 1.11; Supplementary Fig. 3a) and more than
four standard deviations for FDR-signiﬁcant genes (Z-score =
4.19; Supplementary Fig. 3b).
To date, however, only a minority of the >20,000 human genes
have been mapped to HPO terms (N = 3498, build #129), largely
on the basis of phenotypes observed in single-gene Mendelian
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Fig. 3 Gene feature enrichment and expression analysis. a Gene annotation enrichment analysis for CpG probes within signiﬁcant differentially
methylated clusters (DMCs) from the analysis of acutely malnourished children. P values were calculated with hypergeometric tests of depletion or
enrichment comparing N = 420,500 of all tested, background CpG probes with the subset of N = 630 CpG probes found within DMCs. b Intraindividual
correlation (Spearman) between mean methylation and mean expression of highly expressed genes within 10 kb in 20 additional Malawian children with
SAM at individual CpG probes within signiﬁcant DMCs. Horizontal dark bars represent median correlation coefﬁcients, dashed line shows correlation of
zero, and dotted lines indicate thresholds beyond which correlations reach statistical signiﬁcance (algorithm AS 89 t test, P < 0.05). 5′UTR: 5-prime
untranslated region, TSS1500: within 1500 bp distance to transcription start site, TSS200: within 200 bp distance to transcription start site, 3′UTR: 3-prime
untranslated region, IGR: intergenic region. c Beta-value methylation levels by SAM type in DMC overlapping MED24 (left panel, NESAM = 164 samples,
NNESAM = 145 samples) next to scatterplots showing the relationship between methylation levels of probes within the MED24 containing DMC and the
expression values of MED24 (middle and right panel). Gray dashed lines show a linear model ﬁt, while rho values indicate Spearman correlation
coefﬁcients. Source data for panels a and c (density plot) are provided as Source Data ﬁle.

disorders. Therefore, to better understand the link between our
candidate genes and kwashiorkor HPOs, we used gene ontologies,
which collate genes with similar properties, as intermediate links
between HPO-annotated genes and our ESAM genes (Supplementary Fig. 4).
The 1748 genes annotated to HPO terms associated with
kwashiorkor were signiﬁcantly enriched (hypergeometric test,
FDR < 0.01) in 2464 gene ontologies—we refer to these as

kwashiorkor-phenotype gene ontologies (KGOs). We then
assessed how many of the 64 gene ontologies enriched
(hypergeometric test, P < 0.01 vs. background) by the 237 genes
in our Bonferroni-signiﬁcant DMCs (Supplementary Data 5)
were also in the list of KGOs. Just over half (33/64; 50.7%) of
these study gene ontologies (SGOs) were also KGOs, and the
majority of these (29/33; 88%) were also in the top quartile for
signiﬁcance in the KGO list, implying that the gene ontologies
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Fig. 4 Disease gene enrichment in ESAM. a Experimental Factor Ontologies (EFOs) from the GWAS catalog (Methods) with two or more genes
represented among ESAM differentially methylated clusters (DMCs) are shown on the vertical axis and grouped according to their shared parent EFOs.
The overlap between disease and gene is indicated by a shaded box. The color key associated with each box represents the number of genome-wide
signiﬁcant SNPs for each gene for the listed EFO. b Weighted enrichment values for gene ontologies enriched by study DMCs (SGOs; vertical axis) and
phenotypes associated with kwashiorkor (KGOs; horizontal axis) in the Human Phenotype ontology (HPO). SGOs that are not found in the KGO list receive
a value of 0 by default, and SGOs that are found in the KGO list and in the top quartile of both lists would have a value of 1. Ranking of SGOs is indicated in
descending order by the number in front of the SGO term and was based on their aggregate weighted enrichment score.

most highly enriched by our study genes were also highly
enriched among the kwashiorkor phenotypes. We quantiﬁed the
overlap between the two gene ontologies by creating a weighted
enrichment score for SGOs that was maximized by SGOs that
both overlapped the KGO list and had a high signiﬁcance rank
among KGOs (Methods). The kwashiorkor subphenotypes of
immunodeﬁciency and fever, followed by hepatomegaly and
obesity had the strongest SGO scores, again reﬂecting the
signiﬁcance of metabolism, immunity, and the liver to ESAM
pathophysiology (Fig. 4b).
Closer scrutiny of the individual genes encompassed by our
DMCs revealed several candidates with potential importance to
nutrition in general and the ESAM phenotype in particular. For
instance, hepatic steatosis (fatty liver) is associated with obesity
but is also well-described in ESAM36–38, with severe involvement
at the time of diagnosis heralding a poor prognosis39. Our list of
Bonferroni-signiﬁcant hypomethylated genes included NDUFS2
(NADH:Ubiquinone oxidoreductase core subunit S2; Supplementary Fig. 5a), which encodes a subunit of mitochondrial
complex I that has recently been implicated in the development of
malnutrition-related fatty-liver in rats37. PHLDA1 (Pleckstrin
Homology Like Domain Family A Member 1), which encodes a
nuclear protein associated with adipogenesis, was also in one of
our top DMCs; hypermethylation of hepatic Phlda1, with
concomitant transcriptional silencing, has been reported in mice
who developed fatty liver after being fed a high-fat diet40. Other
DMCs included NFE2L1, a nuclear transcription factor integral to
the maintenance of proteasome function in hepatocytes that has
also been implicated in liver steatosis41, and SLC2A4, which
encodes an insulin-regulated facilitative transporter of glucose
(GLUT4) that leads to hepatic steatosis in homozygous knockout
mice42.
6

One of the largest and most signiﬁcantly hypomethylated
DMCs included SOCS3 (Supplementary Fig. 5b), a regulator of
cytokine-, JAK-STAT-, and leptin- signaling, for which changes in
methylation have been associated with metabolic syndrome43,
body mass index (BMI)44, and diabetes45, while changes in
expression in muscle tissue have been associated with diet-induced
metabolic derangements46. These observations, alongside the
occurrence of several other inﬂammatory and immunoregulatory
genes in our top DMCs, including LENG8, CHI3L1, SDK1, and
CSF3 (Supplementary Fig. 5c), provide a potential pathophysiological link with the altered inﬂammatory state noted in ESAM47.
Other DMCs included the O-linked glycosylation pathway enzyme
genes B3GNT7 (Supplementary Fig. 5d), CSGALNACT1, and
ST3GAL3, which may be relevant to observations of reduced
sulfated glycosaminoglycans in intestinal biopsies from children
with acute kwashiorkor16, and AQP1 (Aquaporin 1), a member of
the aquaporin family of transcellular water channels48 that has
been implicated in the development of tissue edema. A potential
role for aquaporins was further supported by an FDR-signiﬁcant
DMC (t test, P = 4.52 × 10−5, FDR = 6.42 × 10−3) that included
two other members of the same family (AQP5 and AQP6;
Supplementary Data 2).
Potential role for sequence variation in acute ESAM. Given the
established association between single nucleotide polymorphisms
(SNPs) and methylation at nearby CpG sites (methylation
quantitative trait loci—meQTLs)49–51, we also sought to determine whether genetic variation in and around our hypomethylated loci might inﬂuence the extent of methylation at our DMCs.
A model of genetic inﬂuence in SAM, however, would need to
account for our observation of differential methylation between
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ESAM and NESAM only being evident during the acute nutritional stress. Context-dependent expression quantitative trait loci
(eQTLs) have been described in the literature52–54, and, although
similar observations for meQTLs are few, both eQTLs and
meQTLs are thought to represent binding sites for transcription
factors (TFs), with meQTLs inﬂuencing the activity of core
methylation enzymes55 instead of directly impacting gene transcription (eQTLs). In the context of acute SAM, therefore, in
which we had some evidence for a complex transcriptional state,
we considered whether there was any evidence for nutritionalstate-dependent meQTLs. We explored this by integrating
methylation data with genome-wide genotyping data available for
138 SAM samples from Jamaica (Methods) and evaluating
meQTLs at our DMCs in the context of acute (DC) and recovered
(DL) samples. Several signiﬁcant (Wald test, P < 3.4 × 10−8)
meQTL signals were observed in both DC (5030 SNP−CpG
pairs) and DL (1346 SNP−CpG pairs) sample groups (Supplementary Fig. 6).
We focused on meQTLs within 10 kb of any of the 1261 DMCs
surpassing our FDR threshold (t test, FDR < 0.01), and, to
account for subdividing of our initial sample, we ﬁrst considered
all SNP−CpG associations of nominal signiﬁcance (Wald test,

P ≤ 0.05; Methods). At these FDR DMCs, 1885 of the 16,792
SNP-CpG pairs met our signiﬁcance threshold among acute (DC)
samples; of these, 162 pairs (~8.5%), representing 111 DMCs
(Supplementary Data 6), had evidence of a signiﬁcant difference
between ESAM and NESAM in the strength of meQTL
association (Wald test, Pinteraction ≤ 0.05) with no evidence of a
similar interaction among recovered (DL) samples (Methods).
This group included 16 SNP−CpG pairs at 14 of our Bonferronisigniﬁcant DMCs (Fig. 5a). At these loci, the genotypemethylation association was signiﬁcant in either acute NESAM
or ESAM but was no longer signiﬁcant at the time of recovery.
Among the 162 disease-speciﬁc meQTLs, 26 SNP-CpG pairs (16
unique loci) were still evident at a more stringent signiﬁcance
threshold (Wald test, P < 1 × 10−4), and the majority of this latter
group (23 of 26) showed strong association in acute ESAM, but
were not signiﬁcant in acute NESAM or among recovered groups
(Fig. 5b, c). Interestingly, almost two-thirds (64.1%) of these
candidate nutrition-sensitive meQTLs were predicted to strongly
alter the likelihood of TF binding56,57, although, a similar
proportion was observed among putative nutrition-insensitive
meQTLs (65.1%; Supplementary Data 7 and 8) and there was
substantial overlap between the two sets of TFs. The ten (8.5%)
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Fig. 5 A model of nutrition-sensitive methylation quantitative trait loci (meQTLs). a Scatterplot of the slopes of the regressions (β1) of SNP genotype on
CpG methylation (meQTLs) at signiﬁcant DMCs in acute (DC) ESAM and NESAM samples (N = 1885 SNP−DMC pairs). FDR-signiﬁcant DMCs with
meQTLs showing a signiﬁcant interaction (t test, P ≤ 0.05) between ESAM and NESAM DC samples, but not among DL samples (N = 162) are highlighted
in black; similar meQTLs found at Bonferroni-signiﬁcant DMCs (N = 16) are in red. b log10 transformed P values of 162 meQTLs with a signiﬁcant
interaction; each dot represents values for the same SNP−CpG pair between acute (DC NESAM vs. DC ESAM) and recovered (DL NESAM vs. DL ESAM)
individuals. c Disease context-dependent meQTLs at LINC01016. Methylation beta values (y axis) and genotypes (x axis) are shown for two adjacent SNP
−CpG pairs (one SNP—two CpGs) illustrating a signiﬁcant ESAM−NESAM interaction (t test, P ≤ 0.05; positive regression slope) in acute (DC, top and
bottom left panels, NESAM = 53 samples, NNESAM = 37 samples) but not recovered SAM (DL, top and bottom right panels, NESAM = 23 samples, NNESAM =
25 samples). Boxplot center lines are medians, box boundaries are ﬁrst and third quartile, and whiskers extend to data points found within 1.5 times the
length of inter quartile range from the median.
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TFs unique to the nutrition-sensitive meQTLs included the
related TFs MLX and MLXIPL, which participate in pathways
associated with nonalcoholic fatty liver disease (NAFLD)58. Given
the modest samples sizes employed and a limited view of African
genetic variation, however, it is likely that some of the nutritioninsensitive meQTLs could be misclassiﬁed and are really
nutrition-sensitive, or that more complex mechanisms of
activation in the context of severe malnutrition could differentiate
the two datasets.
To further explore this nutrition-sensitive meQTL model, we
evaluated our set of meQTLs against meQTLs identiﬁed in the
same tissue in another childhood methylation study, which
analyzed individual methylation differences in monozygotic twin
pairs59. Only 10 (6.2%) out of 162 putative nutrition-sensitive
buccal meQTLs were also found in this reference buccal meQTL
dataset, in contrast to 238 (12.6%) out of 1723 non-nutritionsensitive meQTLs (Fisher’s exact test, P = 0.005). We also
performed a similar analysis using meQTLs assessed across
tissues and age-groups in the ARIES study60. Similar to the
reference buccal meQTLs, we found that only 9 of the 162
putative nutrition-sensitive pairs (5.6%) were identiﬁed as
meQTLs in any ARIES data subset, whereas almost twice the
proportion (11.6%; 200 of 1723) of putative non-nutritionsensitive meQTLs were represented (Fisher’s exact test, P =
0.018; Supplementary Table 2); this was consistent with a model
in which proposed nutrition-sensitive meQTLs remain relatively
quiescent during states of adequate nutrition—that is, the effect
of the SNP on methylation is minimally (or not) evident under
normal circumstances—but becomes manifest during the acute
nutritional stress of SAM.
Discussion
Using genomic and epigenomic platforms that have been applied
to other complex traits, we provide a molecular evaluation of
ESAM. We deliberately focused on differences incurred in the
context of acute starvation, such that the molecular changes
described are speciﬁc to the acute pathology of ESAM, and
relative to NESAM. This differentiates our study from previous
studies of more general malnutrition that are agnostic to the form
of SAM29,30. Similarly, by integrating molecular correlates of
expression and assessing the contribution of cis-acting genetic
variation, we provide a unique view of this gene-environment
response that may hold lessons for other disorders.
Consistent with lower concentrations and slower methyl-ﬂux
of methionine reported in acute, but not recovered, ESAM, we
observed extensive DNA hypomethylation in ESAM children
relative to their NESAM counterparts during the acute insult that
was not evident among recovered individuals. Patterns of
methylation can vary widely between tissues, making extrapolation of single-tissue ﬁndings challenging. We chose buccal epithelium as an easily accessible tissue that is embryologically
related to the gut, one of the major organs affected in ESAM; thus
some of our DMCs may be directly relevant to the emerging
literature on gut pathophysiology in ESAM61. Furthermore,
methylation levels in buccal epithelium often correlate with
methylation in other cells62, which aids in interpreting observed
DMCs as also relevant to other ESAM-disturbed organs, such as
the liver. In fact, 40% of our differentially methylated sites showed
strong correlation (Pearson r ≥ 0.7) between buccal and blood
DNA methylation (Methods, Supplementary Data 9). This
assertion is further bolstered by the aforementioned stableisotope studies of methionine metabolism25, which described the
slowing of whole-body methyl-group turnover in ESAM; this
would be expected to impact DNA methylation patterns across
the breadth of mitotically active tissues.
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Hypomethylation was enriched over gene bodies and, in
additional age-, gender- and SAM-status matched samples,
methylation at differentially methylated loci within gene bodies
correlated with both increased as well as decreased expression at
proximal genes; this suggests that DNA methylation changes
in acute SAM have a complex effect on neighboring gene transcription. Such a complex transcriptional proﬁle in the context
of hypomethylation is consistent with recent studies of the
methylation-expression interface, which have emphasized genome context-dependent, bidirectional associations between
altered DNA methylation and gene transcription63.
Hypomethylated DMCs overlapped genes associated with
organ dysfunction similar to those recorded in ESAM over decades of metabolic and clinical studies4–6,36,64–67. The implicated
genes included disruption of pathways involved in liver pathology, inﬂammation, and metabolism. This latter group also
included genes associated with common nutritional and cardiometabolic disorders. Fatty liver is known to occur in both underand overnutrition; our results suggest that this might reﬂect
regulatory disruptions in a core set of genes, including NDUFS2
and PHLDA1, that lead to steatosis regardless of the directional
effect of the nutritional insult. This was a recurrent theme with
genes related to metabolic stress such as SOCS3, CHI3L1, and
CSF3. Our data suggest that the same genes that are in involved in
obesity/diabetes might also be relevant to ESAM, possibly causing
a mirrored molecular response to the availability of nutrient
energy sources that utilizes similar pathways.
Our observations may also be relevant to the chronic diseases
and long-term health effects described among survivors of acute
starvation68–70. Genes implicated in our ESAM study showed
little-to-no overlap with those noted in a previous study of
methylation in adult survivors of malnutrition29; however, that
study did not include the severity or type of SAM, and primarily
focused on whole blood samples, making direct comparisons
difﬁcult. Nonetheless, it may be that the underlying mechanisms
postulated here are still relevant—mitotic turnover among
growing children is typically higher than in adults; and, whereas
buccal epithelium is dynamically replenished, other cell types
demonstrate less continuous renewal, allowing aberrations in
methylation incurred during childhood to be perpetuated in tissues such as heart or muscle, potentially leading to the long-term
health consequences that have been associated with the divergent
SAM phenotypes30,69,70.
We also observed preliminary evidence for a model of
nutrition-sensitive meQTLs at 8% of our differentially methylated
loci. The diagnosis of ESAM depends upon the clinical recognition of nutritional edema; however, the occurrence (and degree)
of other clinical manifestations, such as skin, hair, or liver
changes, is more variable. Given the relevance of genetic variation
to phenotypic variation, our speculation is that nutrition-sensitive
meQTLs might ﬁne-tune the degree of hypomethylation at
DMCs, akin to genetic modiﬁers of disease, and thereby modulate
the clinical expression of ESAM phenotypes. Given limitations in
genome-wide coverage of African-ancestry populations inherent
in current genotyping platforms71, and differences in ancestral
make-up between SAM cases and tissue- and age-comparable
controls, larger studies utilizing longitudinal sampling in diverse
disease contexts, populations, and cellular/organism models are
required to determine the extent to which this hypothetical model
holds true.
Our ﬁndings do not give a deﬁnitive answer to the longstanding question of the primary cause of kwashiorkor (i.e. what
causes some children to develop kwashiorkor and others
marasmus); however, the epigenetic changes observed provide
a plausible link between observations of altered 1-carbon
metabolism in acute SAM and the clinical manifestations of
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ESAM/kwashiorkor. Whilst we cannot fully assay the effect of
perturbed methylation at the organismal level, children with
SAM are typically ill for days to weeks beforehand, suggesting
the potential for a widespread, systemic shift in biology as part
of the pathophysiology. Outside of cancer biology, there are few
disease states in which epigenetic changes have been clearly
linked to nutritional metabolism. Regulation of DNA methylation is complex and we cannot fully discount that the methylation changes observed here are purely secondary or unrelated
to either 1-carbon metabolism or ESAM; however, given the
interdependencies of 1-carbon metabolism, methyl-group ﬂux
and DNA methylation72,73, our working hypothesis is that the
observed DNA hypomethylation is closely related to the slow
turnover of 1-carbon cycle metabolites, including methionine,
noted in previous studies. The root of this turnover difference
remains obscure but could reﬂect subtle upstream differences in
diet quality or innate handling of dietary nutrients (e.g. genetic
differences in metabolism) or both.
Irrespective of the initiating insult, downstream differences in
pathophysiology that distinguish the two acute clinical states
could still relate to the epigenetic changes observed in ESAM. In
fact, a theoretical link between the biological processes regulated
by 1-carbon metabolism and the organ dysfunction of ESAM was
postulated decades ago74, but never empirically tested. This
provides a context for further integrating biochemical and
metagenomic observations of ESAM with our ﬁndings. The levels
of sulfur-containing 1-carbon amino acids cysteine and methionine in plasma have consistently been shown to be lower in acute
ESAM than NESAM14,25,75, and similar changes have been noted
in response to gut microbiome dysbiosis, which is now welldescribed in malnutrition17,18,76,77. Smith et al.76, for example,
reported signiﬁcantly lower methionine and cysteine levels in
gnotobiotic mice transplanted with the stool microbiome of
children with kwashiorkor than those transplanted with stool
from their healthy twins. Thus, one hypothetical molecular cascade involves the initiation of aberrant 1-carbon metabolism,
exacerbated by gut microbiome dysbiosis, and downstream epigenetic changes that potentiate dysregulation of genes central to
expression of the clinical phenotype. The therapeutic corollary of
this hypothesis is that augmentation of methyl-ﬂux, through
nutritional supplementation of methionine, related 1-carbon
derivatives, or associated methyl-donor cofactors (e.g. choline
or betaine) before or during acute illness, may be a viable way of
abating DNA hypomethylation and mitigating the severity and/or
establishment of acute ESAM78,79, as recently partially suggested
by the administration of choline in a mouse model of hepatic
steatosis induced by undernutrition80.
Methods
Experimental design. Demographics of the samples utilized for the present study
are given in Supplementary Table 1. DNA samples used in the study were from
participants recruited in St. Andrew, Jamaica, and rural sites in ﬁve southern
Malawi districts. In Jamaica, the study was approved by the Ethics Committees of
the UHWI/University of the West Indies Faculty of Medical Sciences. In Malawi,
the study was approved by the National Health Science Review Committee
(NHSRC) of the Ministry of Health, Government of Malawi. In both countries,
written informed consent was obtained from adult participants and the parent or
adult guardian of participating children and all ethical regulations regarding
human participants were complied with. Permission to use the participant samples
for genetic studies at Baylor College of Medicine (BCM) was approved by the
Institutional Review Board (IRB) of BCM.
Participants from Jamaica were recruited as part of a long-standing study of
genetic susceptibility to SAM being undertaken at the Tropical Metabolism
Research Unit (TMRU) of the Caribbean Institute for Health Research (CAIHR) at
the University Hospital of the West Indies (UHWI), located in St. Andrew,
Jamaica. Participants were either current (prospective) or former (retrospective)
patients admitted for in-patient care on the metabolic research ward of TMRU,
which serves as a tertiary referral center for children with severe malnutrition from
the entire island81,82. The principal inclusion criterion for all participants was a
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diagnosis of SAM according to the Wellcome Classiﬁcation83; i.e. marasmus (<60%
weight-for-age; no edema), marasmic-kwashiorkor (<60% weight-for-age with
edema), or kwashiorkor (60–80% weight-for-age with edema). Weight and height
of all individuals was measured at the time of recruitment. Prospectively recruited
individuals, who were sampled within 8 weeks of their hospital admission, were
designated as acute (discharged, DC) samples. Admission records were used to
identify former patients living within a 20-mile radius of TMRU. Among these
SAM survivors, samples from available adults (older than 17 years) were designated
as delayed (DL) samples. The Wellcome classiﬁcation was used in both prospective
and retrospective cohorts in order to facilitate comparability between the groups.
Participants with pre-existing chronic illnesses predisposing to potential secondary
malnutrition (e.g. HIV seropositive, congenital malformations, cerebral palsy) were
excluded from this arm of recruitment.
In Malawi, DNA samples were prospectively obtained between 2013 and 2016
from participants seen at 18 outpatient feeding clinics in rural Malawi84. Each
child’s weight, length, and mid-upper-arm circumference (MUAC) were measured.
Children between 6 and 59 months of age, with nutritional edema (indicative of
kwashiorkor), and those with a MUAC < 11.5 cm (indicative of marasmus), or both
(marasmic-kwashiorkor), were eligible for enrollment. Samples were obtained at
the time of initial diagnosis (acute, DC), and participants were categorized as either
edematous (kwashiorkor and marasmic-kwashiorkor) or nonedematous
(marasmus) for the purposes of the study. MUAC has been noted to be a more
sensitive indicator of acute malnutrition than weight-for-age22,85 and has become
the de facto standard-of-care for the diagnosis of NESAM in much of rural Africa.
Adhering to the recruitment strategy, edematous and nonedematous participants
were matched by age and gender within the study age spectrum. Individuals with
overtly compromised or infected oral mucosa were excluded from the study. Acute
(fever, diarrhea) and chronic (e.g. HIV) illnesses as well as antibiotic use at the time
of recruitment were recorded for each participant.
The mitotic turnover of buccal cells takes anywhere from 5 to 25 days in healthy
individuals86, meaning that incident DNA methylation patterns likely reﬂect
methyl-group turnover in the preceding days to weeks. This is congruent with the
concordance of results between the Jamaica and Malawi DC cohorts, despite slight
differences in the timings of sample acquisition (Supplementary Data 1). Although
SAM classiﬁcation schemes were different in Malawi and Jamaica, we observed that
reclassifying individuals according to the Wellcome criteria in both cohorts
strengthened our associations; this suggests that our analysis is more conservative,
but more applicable to current recommendations for assessing SAM87.
DNA processing and methylation array typing. In Jamaica, two sets of mouth
swabs (ten plastic sterile cotton tip applicators) were used to swab the inner jaw,
with ﬁve strokes of each jaw taken with each swab81. Swabs are then placed in a
15 ml orange top tube with 3 ml of cell lysis solution. In Malawi, buccal epithelium
was sampled using the Oragene Discover (OGR-250) DNA collection kit in conjunction with CS-1 and CS-2 sponges (DNA Genotek Inc., Ottawa, Ontario,
Canada). The protocol was modiﬁed to collect buccal epithelial cells by obtaining
ten passes of each inner cheek using ﬁve swabs. DNA was extracted according to
the manufacturer’s instructions.
The quantity of double-stranded DNA (dsDNA) in each sample was assessed
using plate ﬂuorescence (PicoGreen, Life Technologies, Grand Island, NY).
Bisulﬁte conversion was performed with the EZ-96 DNA Methylation kit in deep
well format (Zymo Research Corp., Irvine, California, USA) on 500 ng of extracted
DNA. A random number generator was used to assign samples to plates ahead of
methylation array typing. DNA methylation was assessed using Illumina’s Inﬁnium
HumanMethylation450 Bead Chip array (Illumina, Inc., San Diego, California,
USA) following the manufacturer’s recommendations for the manual process
outlined in the Inﬁnium HD Assay Methylation Protocol Guide.
Methylation array processing. IDAT ﬁles for all samples, containing raw ﬂuorescence intensity values, were collated and analyzed in R using the ChAMP package
(version 1.8.2)88 to identify low-quality samples. Out of an initial total of 407,
33 samples with >2% failed probes were excluded (all from Jamaica, 19 DL). All
remaining 374 samples (Supplementary Table 1) were imported simultaneously
using the Methylation Module (version 1.9.0) in Illumina’s GenomeStudio software
(version 2011.1). Reading all samples together reduced the potential for batch
effects in downstream data. Background ﬂuorescence intensity values were subtracted from the remaining IDAT ﬁles without control normalization. The
resulting ﬂuorescence intensity values were color balanced and quantile normalized
using the R package lumi (version 2.22.1)89. Probes meeting the following criteria
were omitted from subsequent analyses: internal controls (N = 65), detection
P value < 0.0001 in >10% of samples (N = 860), bead counts <3 in 5% of samples
(N = 665), sex chromosomes (N = 11,288), cross-reactive (N = 29,895), and containing SNPs with a minor allele frequency (MAF) >0.01 in African populations at,
or within 5 bp of, the single base extension (SBE) site (N = 16,918 and N = 5386,
respectively)90. A total of 420,500 probes remained for differential methylation
analysis. All reported genome coordinates were referenced to hg19.
Methylation analysis. Methylation estimates resulting from the lumi preprocessing steps in the form of M values were normalized using the qqnorm function in
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R (v3.4.1). Processing with the COMBAT module of the ChAMP suite88 showed no
evidence for systematic biases on the basis of chip or batch using single value
decomposition (Supplementary Fig. 7).
Resulting M values were ﬁt to a linear regression model to identify single probes
with evidence of differential methylation between ESAM and NESAM samples:
M i ¼ Ca þ Yb þ e, where M = normalized methylation value at probe i, Ca =
matrix of covariates, Yb = matrix of case (ESAM) or control (NESAM) status, and
e = random error. Acute (DC) samples were analyzed separately from adult
recovered (delayed; DL) samples. Principal component analysis (PCA) using
methylation values for all probes demonstrated no systematic global differences
between DC samples from Jamaica and Malawi (Supplementary Fig. 8), and these
were combined to increase the available sample size and mitigate age differences
between ESAM and NESAM children observed in each country. In the subsequent
analysis, age, gender, and the ﬁrst principal component (PC1), which accounted for
20.6% of the variance in the data, were utilized as covariates. Preference was given
to PC1 as a covariate over geographic sampling location as it improved the
genomic inﬂation factor (from 1.24 to 1.16) and thus likely encompassed other
sample variation in addition to location; inclusion of additional principal
components was found to increase the genomic inﬂation factor (Supplementary
Table 3). For the DL analysis, there were no systematic sample differences noted on
PCA (Supplementary Fig. 8); gender and age were included as covariates.
To provide evidence that differentially methylated sites were consistent across
countries, DC individuals from each country group were also assessed separately.
In the Jamaican DC cohort, ESAM children were signiﬁcantly younger than those
with NESAM, and vice versa in the Malawian DC cohort (Supplementary Table 1).
To account for this confounding, age was omitted as a covariate in the countryspeciﬁc methylation analysis, and instead, 2459 probes shown to be sensitive to age
in buccal epithelial cells91 were removed. Gender was utilized as a covariate under
the same linear regression model used for the joint analysis.
We validated our results from the 450 K beadchip by performing capture-based
bisulﬁte sequencing (SeqCap Epi CpGiant Enrichment Kit, Roche NimbleGen, Inc.,
Madison, Wisconsin, USA)92 on three samples from Jamaica that also had arraybased methylation. Overall correlation between array and sequencing at
overlapping high-quality sites was 0.95 (Pearson’s r; Supplementary Fig. 9).
Methylation clustering using CpG correlation. Methylation at neighboring CpG
loci tends to be correlated31; therefore, in order to reduce false positive associations
at individual sites, adjacent CpG sites were binned into clusters on the basis of their
magnitude and direction of association. Single probes with effect sizes [betaslope]
between −0.05 and +0.05 were removed to reduce ambiguity of the direction of
effect at the margins of association, which could change cluster assignment. Of the
166 Bonferroni DMCs, 19 would have included >2 of these marginal probes. The
remaining probes were binned into nonoverlapping clusters in which the distance
between adjacent probes was at most 10 kb, and all binned probes shared the same
direction of effect (Supplementary Fig. 10). This resulted in 135,053 and 173,635
clusters for the DC and DL analyses, respectively. The regression analysis described
above was then repeated using the mean M values of all probes within a cluster as
the dependent variable. The resulting DC clusters encompassed anywhere from 1
to 43 probes, with a median size of 1.7 kb (range 4 bp to 41.5 kb for clusters with >2
probes).
Cellular composition of samples. To conﬁrm that our DNA samples were primarily derived from buccal epithelial cells in our dataset of 309 DC and 65 DL
samples, we isolated available CpG sites that were needed for the online Horvath
DNA methylation age calculator (accessed September 21, 2017)93, which provides
probabilities for potential tissues of origin based on tissue-speciﬁc methylation
patterns. According to the tissue prediction algorithm, 97.4% of the 309 DC
samples were primarily buccal (epithelial) in origin (median probability of predicted buccal samples: 0.84), and this proportion was similar in ESAM (162/164
(98.8%)) and NESAM 139/145 (95.9%) (Supplementary Fig. 11). Similarly, a secondary method of cell type heterogeneity assessment, EpiDISH94 used in combination with EpiFibIC reference data95 and its robust partial correlations (RPC)
method, predicted epithelial as the major cell fraction in 91.6% (283/309) of acutely
malnourished children, with no difference between ESAM and NESAM (chisquared test, P = 0.12). This was consistent with anecdotal reports from ﬁeld
recruitment that many of the acutely malnourished children were also dehydrated
and had insufﬁcient saliva for collection. We also performed capture methylation
sequencing of buccal and peripheral blood DNA sampled <3 days apart from the
same three individuals; mean Pearson correlation within-individuals (0.84) was less
than between the same tissues from different individuals (0.96). Pearson correlation
between buccal and blood methylation from bisulﬁte sequencing data was assessed
at 116/157 Bonferroni-signiﬁcant single sites that were captured at any coverage in
both tissues and had nonzero variance between samples. Among DL adult samples,
58.5% were estimated to be primarily buccal epithelial (median probability of
predicated buccal samples: 0.31), while the remaining samples were predicted to
have originated from saliva (40.0%) or whole blood (1.5%); however, this proportion was not signiﬁcantly different between former ESAM and NESAM.
Similarly, our secondary method predicted epithelial as the major cell fraction in
27.7% (18/65) of adult samples, without differences in ESAM and NESAM (chisquared test, P = 0.82). On the basis of these results we concluded that the primary
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comparisons between ESAM and NESAM in each group are not signiﬁcantly
impacted by cellular composition, although this may have a greater impact on
comparisons between DC and DL groups.
Pearson correlation was assessed between blood and buccal at CpG loci that
passed the Bonferroni threshold of signiﬁcance in our single site analysis and that
were captured by bisulﬁte sequencing, according to the approach described in
ref. 92, in the three individuals with paired buccal and blood samples
(Supplementary Data 9).
Gene ontology and pathway enrichment analysis. RefSeq genes overlapping or
within 10 kb of Bonferroni-signiﬁcant clusters were taken as candidate genes.
ConsensusPathDB’s over-representation analysis (accessed June 29, 2017)96 was
used to identify enriched gene ontologies (hypergeometric test, FDR < 0.01) associated with these candidates. RefSeq genes overlapping or within 10 kb of the CpG
loci targeted by the array were used as background. Gene ontology analysis
included all levels with default parameters.
GWAS study enrichment score. The NHGRI-EBI catalog of published genomewide association studies (GWAS)33 includes GWAS hits labeled with terms from
Experimental Factor Ontology (EFO; https://www.ebi.ac.uk/efo/). We ﬁrst considered EFO labels of GWAS hits that were mapped to one of our top differentially
methylated genes. Each pair of an EFO and gene was then given a score based on
the number of SNPs mapped to the gene in separate GWAS hit records labeled
with the EFO term. The ﬁnal scores were then projected onto the differentially
methylated genes, focusing on EFOs represented by more than one gene. To assess
the relative likelihood of individual EFOs, we generated a list of 237 genes
(replicating the number of genes associated with our Bonferroni-signiﬁcant loci)
randomly selected from the list of 20,622 genes linked to 450 K array probes. This
random selection was repeated 10,000 times and the GWAS enrichment score was
evaluated in each instance.
Phenotype-gene ontology scores. Human Phenotype Ontology terms34,35 associated with kwashiorkor were used as ESAM-associated phenotypes, with the
exception of global developmental delay, which was considered to be an overly
broad term for development in acute malnutrition (motor delay was retained).
From this list, genes associated with each term were obtained from the HPO site
(build #129; accessed June 2017). These genes were then run through ConsensusPathDB as described above, using the same set of background genes, to
derive a set of kwashiorkor-phenotype gene ontologies (KGO) with FDR < 0.01.
To quantify the overlap between study gene-ontologies (SGO) (Supplementary
Fig. 4; Supplementary Data 5) and phenotypes associated with kwashiorkor, we
derived a weighted enrichment score. First, enriched SGOs and KGOs were ranked
by P value, such that each SGO ontology was given a value equal to the P value
quartile in which it fell (i.e. 1, 0.75, 0.5, 0.25) multiplied by its scaled quartile place
in the KGO list. Therefore, SGOs that are not found in the KGO list receive a score
of 0 by default, and SGOs that are found in the KGO list and in the top quartile of
both lists would have a score of 1 (the highest score). Then, for each kwashiorkor
HPO term, we identiﬁed the genes associated with that term and calculated the
proportion of those genes that mapped to each SGO. The ﬁnal score for each SGO
−phenotype pair was then derived by taking the arithmetic mean of the two scores
((quartile score + proportion score)/2); this ﬁnal score ranged from 0 to 1.
DNA/RNA dual collection and processing. Twenty-eight additional Malawian
DC buccal samples had both DNA and RNA isolation, and these were used for
gene expression-methylation correlation analysis. DNA was extracted as outlined
above, and methylation was assessed using the Illumina EPIC methylation kit in
24 samples following procedures as outlined for the main dataset. The Oragene
RNA (RE-100) RNA collection kit was used in conjunction with CS-2 sponges
(DNA Genotek Inc., Ottawa, Ontario, Canada) with modiﬁcation, to collect buccal
epithelial cells from multiple cheek swabs. RNA was extracted according to the
manufacturer’s instructions. Gene expression analysis was undertaken for 24 samples using the Affymetrix GeneChip human Clariom S assay (Thermo Fisher
Scientiﬁc, Waltham, Massachusetts, USA) following the recommendations of the
GeneChip WT PLUS Reagent Kit—Target Preparation for GeneChip Whole
Transcript (WT) Expression Arrays manual.
Expression analysis. Gene expression levels in the form of ﬂuorescence intensity
values stored in CEL ﬁles were background corrected and normalized on Affymetrix’s Expression Console software (build 1.4.1.46, Thermo Fisher Scientiﬁc,
Waltham, Massachusetts, USA) using the SST-RMA algorithm. Probe sets with
expression levels twofold above the mean expression levels of the antigenomic
control probes, which are designed to be incompatible with any human genome
sequence, were considered as expressed.
Methylation-expression correlation. Paired DNA methylation and expression
data were available for 20 out of 28 samples (remaining samples failed quality
control for either methylation or gene expression, or both), who did not differ from
the previous Malawian cohort with regard to age, gender, and ESAM/NESAM
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proportions. Spearman correlation coefﬁcients were calculated between the
methylation beta- and M values for each CpG site and the expression value for each
gene within 10 kb of the differentially methylated cluster into which the site was
binned. Only genes with expression levels twofold above the antigenomic background were assessed. This resulted in 151 CpG-gene expression comparisons,
consisting of 146 unique CpG loci and 25 unique expressed gene transcripts,
corresponding to 25 genes. A post-hoc power analysis using G*Power (version
3.1.9.2)97, set to exact test family and correlation: bivariate normal mode with
α = 0.05 and N = 20, revealed that, dependent on the minimum (|rho| = 0.45) or
maximum (|rho| = 0.65) coefﬁcient associated with signiﬁcant correlations, our
analysis has a power of 53% or 91%, respectively.

Code availability

Genotyping. DNA samples from the broader Jamaica cohort81,82 were genotyped
on two separate genotyping platforms: HumanOmni1-Quad BeadChip (Illumina,
San Diego, CA) and HumanOmni2.5 BeadChip (Illumina, San Diego, CA). Quality
control was performed for SNPs and samples in each phase individually and then
on the merged set. GenomeStudio software (Illumina) was used to interpret normalized ﬂuorescence intensities as genotypes. SNPs with more than 2% missing
data (genotyping efﬁciency <0.98), SNPs out of Hardy−Weinberg equilibrium
(exact test, P < 1 × 10−3), or with MAF < 0.05 were removed. Samples with more
than 2% missing data (genotyping efﬁciency <0.98), or with evidence of excessive
inbreeding (inbreeding coefﬁcient, F > 0.1) were removed. Pairs of samples with
excess allele sharing suggestive of close familial relationships (parent−offspring,
siblings; Pi_HAT > 0.1) were identiﬁed using identity-by-descent (IBD) analyses,
and in such cases one member of the pair was removed from analysis (N = 22).
After merging of datasets and sample quality control (QC), 384 samples and
450,012 autosomal SNPs remained; 138 samples had both adequate genotyping and
methylation data for analysis after QC (53 ESAM-DC, 37 NESAM-DC, 23 ESAMDL, and 25 NESAM-DL).
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